Related Experiment Videos
Mycoplasma pneumonia presenting as meningoencephalitis and hemolytic anemia
The American Journal of the Medical Sciences
|November 1, 1979
Abstract:
Simultaneous occurrence of cold agglutinin hemolytic anemia and central nervous system disease due to Mycoplasma pneumonia is extremely rare. A patient is described who initially presented with severe hemolysis and diffuse neurologic dysfunction which appeared during the period of roentgenographic resolution of her pneumonia. Spectrum, pathogenesis, and antimicrobial treatment of the neurologic complications are reviewed.
Insights
This case study highlights a rare instance of cold agglutinin hemolytic anemia and central nervous system disease occurring together due to Mycoplasma pneumonia. The patient experienced severe hemolysis and neurological issues during pneumonia recovery.
Area of Science:
- Neurology
- Hematology
- Infectious Diseases
Background:
- Mycoplasma pneumonia can trigger autoimmune phenomena, including cold agglutinin disease.
- Central nervous system (CNS) involvement secondary to Mycoplasma pneumonia is uncommon.
- Simultaneous presentation of hemolytic anemia and CNS disease is exceptionally rare.
Observation:
- A patient presented with severe autoimmune hemolytic anemia (cold agglutinin type) and diffuse neurological dysfunction.
- Neurologic symptoms emerged as the patient's Mycoplasma pneumonia began to resolve radiographically.
- The patient's presentation underscores the potential for Mycoplasma pneumonia to induce severe, multi-systemic autoimmune complications.
Findings:
- The case illustrates the rare co-occurrence of cold agglutinin hemolytic anemia and CNS disease.
- The temporal relationship suggests a causal link between Mycoplasma pneumonia infection and the subsequent autoimmune manifestations.
- Review of literature indicates a need for awareness regarding the spectrum of neurologic complications and their management.
Implications:
- This case emphasizes the importance of considering autoimmune complications in patients with Mycoplasma pneumonia, even during recovery.
- Early recognition and appropriate management of both hematologic and neurologic symptoms are crucial for patient outcomes.
- Further research into the pathogenesis of Mycoplasma-induced autoimmune neurological disorders is warranted.